221 related articles for article (PubMed ID: 26415875)
1. Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature.
Izquierdo C; Velasco R; Vidal N; Sánchez JJ; Argyriou AA; Besora S; Graus F; Bruna J
Neuro Oncol; 2016 May; 18(5):707-15. PubMed ID: 26415875
[TBL] [Abstract][Full Text] [Related]
2. Clinical and imaging features of lymphomatosis cerebri: analysis of 8 cases and systematic review of the literature.
Fan M; Zhao L; Chen Q; Zhang M; Zhang X; Yang Z; Li S; Song Y
Clin Exp Med; 2023 Dec; 23(8):4673-4680. PubMed ID: 37979126
[TBL] [Abstract][Full Text] [Related]
3. The Cleveland Clinic experience with primary central nervous system lymphoma.
Xie H; Ahluwalia MS; Peereboom DM
Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
[TBL] [Abstract][Full Text] [Related]
4. Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features.
Yu H; Gao B; Liu J; Yu YC; Shiroishi MS; Huang MM; Yang WX; Guan ZZ
Cancer Imaging; 2017 Oct; 17(1):26. PubMed ID: 28982392
[TBL] [Abstract][Full Text] [Related]
5. Neuroradiological features of lymphomatosis cerebri: A systematic review of the English literature with a new case report.
Li L; Rong JH; Feng J
Oncol Lett; 2018 Aug; 16(2):1463-1474. PubMed ID: 30008825
[TBL] [Abstract][Full Text] [Related]
6. Motor deficits at presentation and predictors of overall survival in central nervous system lymphomas.
Lo YT; Ang YLS; Yang VS; Kanavathy DT; Liang S; Lee L
J Neurooncol; 2021 Jan; 151(2):295-306. PubMed ID: 33398535
[TBL] [Abstract][Full Text] [Related]
7. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
8. Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.
Karmali R; Nabhan C; Petrich AM; Raizer J; Peace D; Lukas R; Gordon LI; Basu S; Chukkapalli V; Venugopal P
Br J Haematol; 2017 Apr; 177(1):72-79. PubMed ID: 28211579
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
[TBL] [Abstract][Full Text] [Related]
10. The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma.
Madle M; Krämer I; Lehners N; Schwarzbich M; Wuchter P; Herfarth K; Egerer G; Ho AD; Witzens-Harig M
Ann Hematol; 2015 Nov; 94(11):1853-7. PubMed ID: 26268792
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004.
Shibamoto Y; Ogino H; Suzuki G; Takemoto M; Araki N; Isobe K; Tsuchida E; Nakamura K; Kenjo M; Suzuki K; Hosono M; Tokumaru S; Ishihara S; Kato E; Ii N; Hayabuchi N
Neuro Oncol; 2008 Aug; 10(4):560-8. PubMed ID: 18559969
[TBL] [Abstract][Full Text] [Related]
12. Diffuse large B-cell lymphoma of the central nervous system presenting as "lymphomatosis cerebri" and dementia in elderly man: Case report and review of the literature.
Kerbauy MN; Pasqualin DDC; Smid J; Iquizli R; Kerbauy LN; Nitrini R; Ribas GC; Neder L; Hamerschlak N
Medicine (Baltimore); 2019 Feb; 98(6):e14367. PubMed ID: 30732171
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma.
Hirono S; Iwadate Y; Higuchi Y; Serizawa T; Nagano O; Matsutani T; Saeki N
J Neurooncol; 2015 Jun; 123(2):237-44. PubMed ID: 25911295
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
[TBL] [Abstract][Full Text] [Related]
16. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
17. "Slow and Steady" Infiltrates the Brain: An Autopsy Report of Lymphomatosis Cerebri.
Gupta K; Gupta V; Radotra BD; Tewari MK
Neurol India; 2019; 67(6):1504-1508. PubMed ID: 31857546
[TBL] [Abstract][Full Text] [Related]
18. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.
Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N
Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330
[TBL] [Abstract][Full Text] [Related]
19. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.
Lim T; Kim SJ; Kim K; Lee JI; Lim DH; Lee DJ; Baek KK; Lee HY; Han B; Uhm JE; Ko YH; Kim WS
Ann Hematol; 2011 Dec; 90(12):1391-8. PubMed ID: 21479535
[TBL] [Abstract][Full Text] [Related]
20. MRI findings in lymphomatosis cerebri: description of a case and revision of the literature.
Raz E; Tinelli E; Antonelli M; Canevelli M; Fiorelli M; Bozzao L; Di Piero V; Caramia F
J Neuroimaging; 2011 Apr; 21(2):e183-6. PubMed ID: 20345746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
